May 21, 2018 3:57 PM ET

Biotechnology

Company Overview of Prevtec Microbia Inc.

Company Overview

Prevtec Microbia Inc., a biotechnology company, develops, manufactures, and markets technologies and products for the prevention of bacterial infections and the improvement of performance in food animal production. It offers Coliprotec, a live vaccine to prevent post-weaning diarrhea (PWD) in pigs caused by F4 (K88)-positive E. coli bacteria. Prevtec Microbia Inc. was founded in 2003 and is based in Montreal, Canada it has operations in Canada and Europe.

1250 Rene-Levesque Boulevard West

Suite 3800

Montreal, QC H3B 4W8

Canada

Founded in 2003

Phone:

514-905-0401

Fax:

514-397-8451

Key Executives for Prevtec Microbia Inc.

Chief Executive Officer, President and Director
Co-Founder, Vice-President of Scientific Affairs and Director
Director of Finance
Vice President - Corporate Development
Compensation as of Fiscal Year 2017.

Prevtec Microbia Inc. Key Developments

Prevtec Microbia Inc. Receives Market Authorization from USDA for Coliprotec® F4

Prevtec Microbia Inc. announced that it has received a market authorization from the Centre for Veterinary Biologics U.S. of the Department of Agriculture (USDA-CVB) to commercialize its vaccine Coliprotec® F4 in the US, a front line product against post weaning diarrhea (PWD) in pigs. This represents a very important addition to Prevtec's growing list of market authorizations for its Coliprotec® family of vaccines. Coliprotec® F4 can now be sold across the Americas, from Canada to the US and to Brazil, accounting for a combined population of more than 140 million pigs annually.

Prevtec Microbia Inc. Receives Market Authorization for Coliprotec F4/F18 in Russia and CIS Countries

Prevtec Microbia Inc. announced that a market authorization was received for Russia, including all CIS countries, for its bivalent vaccine Coliprotec® F4/F18, a front line product against post weaning diarrhea (PWD) in pigs caused by E.coli. Coliprotec® F4/F18 is the first single-dose oral vaccine intended for active immunization of pigs against a broad range of E. coli, being F4-ETEC and F18-ETEC, causing post-weaning diarrhea a major disease leading to economic losses for swine producers.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prevtec Microbia Inc., please visit www.prevtecmicrobia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.